ETHYL 2-(2,6-DICHLORO-9H-PURIN-9-YL)ACETATE, 90.0%, 2g

(E)-N-(4-((E)-3,5-Dimethoxystyryl)phenyl)-3-(3,4,5-trimethoxyphenyl)acrylamide, 98%, 25mg

(5-Bromothiazol-2-yl)methanamine hydrochloride, 95.0%, 1g

Benzyl azetidin-3-yl(methyl)carbamate hydrochloride, 98%, 5g

4-Methoxymethyl-piperidine, 95.0%, 250mg

ETHYL 6-(TRIFLUOROMETHYL)PIPERIDINE-3-CARBOXYLATE, 95.0%, 1g

5-Iodo-2-methoxypyrimidine, 95.0%, 5g

Éter monobutílico de dipropilenglicol, mín. 98 %, para síntesis, 2,5 l, envase de plástico.

2-Propyn-1-ol>98.0%(GC)25mL

(1R,2R)-2-CARBAMOYLCYCLOHEXANECARBOXYLIC ACID, 95.0%, 250mg

8-BENZYL-1,3,8-TRIAZASPIRO[4.5]DECANE-2,4-DIONE, 95.0%, 25g

(S)-3-(BOC-AMINO)-1-CHLORO-2-BUTANONE, 97.0%, 250mg

3-CHLORO-2-CYCLOPROPYLPYRIDINE, 95.0%, 1g